Graypoint LLC Buys Shares of 434 Axon Enterprise, Inc. (NASDAQ:AXON)

Graypoint LLC bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, HoldingsChannel reports. The institutional investor bought 434 shares of the biotechnology company’s stock, valued at approximately $258,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Insigneo Advisory Services LLC raised its position in Axon Enterprise by 1.4% in the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock valued at $627,000 after purchasing an additional 22 shares during the period. Menard Financial Group LLC raised its position in Axon Enterprise by 0.8% in the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after purchasing an additional 24 shares during the period. PFG Investments LLC raised its position in Axon Enterprise by 0.6% in the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after purchasing an additional 25 shares during the period. Gladstone Institutional Advisory LLC raised its position in Axon Enterprise by 1.6% in the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock valued at $656,000 after purchasing an additional 26 shares during the period. Finally, Mather Group LLC. increased its position in shares of Axon Enterprise by 3.7% during the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock worth $303,000 after acquiring an additional 27 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other news, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total transaction of $437,980.00. Following the completion of the sale, the director now owns 26,259 shares in the company, valued at approximately $11,500,916.82. This represents a 3.67 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, President Joshua Isner sold 20,000 shares of the stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the sale, the president now owns 208,166 shares of the company’s stock, valued at $126,179,820.90. This trade represents a 8.77 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 51,545 shares of company stock worth $31,159,317 over the last 90 days. Corporate insiders own 6.10% of the company’s stock.

Analysts Set New Price Targets

AXON has been the topic of a number of recent research reports. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. The Goldman Sachs Group upped their price objective on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Northland Securities upped their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Robert W. Baird upped their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, TD Cowen began coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus target price of $504.92.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $570.00 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 1 year low of $246.99 and a 1 year high of $698.67. The company has a market capitalization of $43.47 billion, a PE ratio of 147.29, a P/E/G ratio of 14.19 and a beta of 1.04. The company has a fifty day moving average of $607.29 and a two-hundred day moving average of $451.03.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.